Blue Edge Capital’s CVS Health CVS Stock Holding History

Blue Edge Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24,902	Closed	-$1.45M	–	100
2020 Q3	$1.45M	Sell	24,902 -1,196	-5%	-$74.4K	0.4%	56
2020 Q2	$1.7M	Buy	26,098 +4,113	+19%	+$259K	0.51%	50
2020 Q1	$1.3M	Buy	21,985 +8,395	+62%	+$560K	0.47%	48
2019 Q4	$1.01M	Sell	13,590 -4,834	-26%	-$339K	0.32%	57
2019 Q3	$1.16M	Sell	18,424 -180	-1%	-$10.7K	0.4%	49
2019 Q2	$1.01M	Buy	18,604 +5,178	+39%	+$279K	0.36%	52
2019 Q1	$724K	Buy	13,426 +5,179	+63%	+$320K	0.27%	63
2018 Q4	$540K	Buy	+8,247	New	+$616K	0.23%	65
2016 Q3	–	Sell	-6,514	Closed	-$624K	–	79
2016 Q2	$624K	Hold	6,514	–	–	0.35%	66
2016 Q1	$676K	Buy	6,514 +319	+5%	+$31K	0.4%	63
2015 Q4	$606K	Sell	6,195 -9	-0.1%	-$881	0.4%	57
2015 Q3	$599K	Buy	+6,204	New	+$652K	0.43%	56

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Blue Edge Capital's CVS Position: Q4 2020 in Review

Blue Edge Capital sold out of CVS Health (CVS) in Q4 2020, closing a stake of 24,902 shares — an estimated $1.45M sold.

Blue Edge Capital first reported a position in CVS in Q3 2015 and held it in 12 quarters. The position peaked at $1.7M in Q2 2020. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

Blue Edge Capital reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
Blue Edge Capital sold 24,902 CVS Health shares in Q4 2020, an estimated $1.45M.
Blue Edge Capital first reported a position in CVS Health in Q3 2015 and held it in 12 quarters.
Blue Edge Capital's CVS Health position peaked at $1.7M in Q2 2020.
1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Blue Edge Capital's 13F filing for Q4 2020, filed 9 Feb 2021.